S-NITROSYLATION OF THE NMDA SUBTYPE OF GLUTAMATE RECEPTOR FOR NEUROPROTECTION
S-NITROSYLATION OF THE NMDA SUBTYPE OF GLUTAMATE RECEPTOR FOR NEUROPROTECTION
批准号:
6307535
负责人:
STUART A LIPTON
金额:
$0.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30
中文摘要
在许多神经系统疾病中,可能会引起神经元损伤,
英文摘要
In many neurological disorders, injury to neurons may be caused,
at least in part, by overstimulation of receptors for excitatory amino
acids, including glutamate, aspartate and related congeners. These
neurological conditions range from acute insults such as stroke,
hypoglycemia, trauma, and epilepsy, to chronic neurodegenerative
states such as Huntington's disease, AIDS dementia complex,
amyotrophic lateral sclerosis, and perhaps Alzheimer's disease.
Glutamate is the major excitatory neurotransinitter in the brain and
as such its interactions with specific membrane receptors are
responsible for many normal neurological functions including
cognition, memory, movement, and sensation. In addition, excitatory
neurotransmitters are important in shaping the developmental
plasticity of synaptic connections in the nervous system. However, in
a variety of pathological conditions, including stroke and various
neurodegenerative disorders, excessive activation of glutamate
receptors may mediate neuronal injury or death. Olney coined the term
'excitotoxicity' for this condition, which may constitute a final
common pathway for neuronal injury from diseases of diverse
pathophysiology. This form of injury appears to be predominantly
mediated by excessive influx of Ca2+ into neurons through ionic
channels triggered by activation of glutamate receptors. An important
point concerning these glutarnate receptor subtypes is that the
N-methel-D-aspartate (NMDA) subtype of glutamate receptoractivated
channel permits the influx of Ca2+ as well Na as+9 and overstimulation
of this type of receptor is thought to be the predominant mechanism
for calcium overload in neurons. Ca2+ influx triggered via NMDA
receptor stimulation activates a variety of enzymes including nitric
oxide synthase and the consequent production of nitric oxide. When
NMDA receptors are excessively stimulated, nitric oxide may be
produced in increased quantities. Under these conditions, NO- and
02'- may react to form a toxic substance called peroxynitrite (ONOO-),
resulting in neuronal death In contrast, nitric oxide can be converted
to a different chemical state that has just the opposite effect,
protecting neurons from injury due to NMDA receptor overstimulation.
The chemical state is dependent upon the removal or addition of an
electron to nitric oxide, a condition that can be influenced by the
presence or absence of electron donors, such as ascorbate or the amino
acid cysteine. For example, with one less electron, NOmay yield a
substance with NO+ (nitrosonium) character. In this form, the NO
group appears to be transferred to a regulatory site on the NMDA
receptor, termed the redox modulatory site. This site is comprised of
sulfhydryl (-SH) groups; the reaction of -S- with NO+ to form -SNO (a
process called Snitrosylation) results in decreased activity of the
NMDA receptor, thus affording protection from excessive stimulation.
Therefore, depending on its chemical state, the NO moiety can lead to
neurodestruction or neuroprotection. These findings have lead to
therapeutic approaches to decrease NMDA receptor overactivity using
drugs with NO+ character, such as nitroglycerin. NMDA Redox
Modulatory Site The motivating force behind the work proposed here is
to characterize the cysteine residues comprising the redox modulatory
site(s) of the NMDA receptor with respect to their interaction with
the NO group. Work from our laboratory with recombinant NMDA receptor
subunits has shown that two cysteine residues on the NMDARI subunit of
the NMDA receptor are involved in redox modulation (cysteine residues
744 and 798; Fig .1, below). In collaboration with the Chait
laboratory, we propose to use electrospray ionization mass
spectrometry to visualize S-nitrosylatoin of the NMDARI subunit, to
determine if intra- or intermolecular disulfide bond formation
subsequently occurs, and to correlate these findings with the know
regulatory activity of these reactions on the NMDA receptor from our
patch-clamp electrophysiological studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
-
批准号:10686979
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2022
-
负责人:STUART A LIPTON
-
依托单位:
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
-
批准号:10515987
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2022
-
负责人:STUART A LIPTON
-
依托单位:
Leadership in AD/ADRD Drug Discovery
-
批准号:10193424
-
项目类别:
-
资助金额:$106.26万
-
财政年份:2021
-
负责人:STUART A LIPTON
-
依托单位:
Leadership in AD/ADRD Drug Discovery
-
批准号:10687169
-
项目类别:
-
资助金额:$108.36万
-
财政年份:2021
-
负责人:STUART A LIPTON
-
依托单位:
Leadership in AD/ADRD Drug Discovery
-
批准号:10461746
-
项目类别:
-
资助金额:$106.26万
-
财政年份:2021
-
负责人:STUART A LIPTON
-
依托单位:
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
-
批准号:10230417
-
项目类别:
-
资助金额:$88.56万
-
财政年份:2020
-
负责人:STUART A LIPTON
-
依托单位:
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
-
批准号:10256731
-
项目类别:
-
资助金额:$87.62万
-
财政年份:2020
-
负责人:STUART A LIPTON
-
依托单位:
S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease
-
批准号:9919542
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2017
-
负责人:STUART A LIPTON
-
依托单位:
S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease
-
批准号:9355868
-
项目类别:
-
资助金额:$67.72万
-
财政年份:2017
-
负责人:STUART A LIPTON
-
依托单位:
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse
-
批准号:9884749
-
项目类别:
-
资助金额:$96.75万
-
财政年份:2016
-
负责人:STUART A LIPTON
-
依托单位:
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse
-
批准号:9249520
-
项目类别:
-
资助金额:$62.35万
-
财政年份:2016
-
负责人:STUART A LIPTON
-
依托单位:
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse
-
批准号:9599797
-
项目类别:
-
资助金额:$51.83万
-
财政年份:2016
-
负责人:STUART A LIPTON
-
依托单位:
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse
-
批准号:10097476
-
项目类别:
-
资助金额:$44.37万
-
财政年份:2016
-
负责人:STUART A LIPTON
-
依托单位:
Modeling Parkinson's Disease with Isogenic hiPSC-Derived Dopaminergic Neurons
-
批准号:9037719
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2014
-
负责人:STUART A LIPTON
-
依托单位:
Modeling Parkinson's Disease with Isogenic hiPSC-Derived Dopaminergic Neurons
-
批准号:8828822
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2014
-
负责人:STUART A LIPTON
-
依托单位:
Modeling Parkinson's Disease with Isogenic hiPSC-Derived Dopaminergic Neurons
-
批准号:9313954
-
项目类别:
-
资助金额:$23.62万
-
财政年份:2014
-
负责人:STUART A LIPTON
-
依托单位:
Modeling Parkinson's Disease with Isogenic hiPSC-Derived Dopaminergic Neurons
-
批准号:8671579
-
项目类别:
-
资助金额:$42.66万
-
财政年份:2014
-
负责人:STUART A LIPTON
-
依托单位:
Transnasal Delivery of Chemokine Analogs in mouse NeuroAIDS Models
-
批准号:8658939
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2013
-
负责人:STUART A LIPTON
-
依托单位:
Transnasal Delivery of Chemokine Analogs in mouse NeuroAIDS Models
-
批准号:8739326
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2013
-
负责人:STUART A LIPTON
-
依托单位:
Protection of Brain Injury from Cyanide Poisoning by Carnosic Acid
-
批准号:8417224
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2012
-
负责人:STUART A LIPTON
-
依托单位:
海外基金